United
States
Securities
and Exchange Commission
Washington,
D.C. 20549
FORM
8-K
Current
Report Pursuant to
Section
13 or 15(d) of the Securities Exchange Act of 1934
September
28, 2010
(Date of Report)
ULTRALIFE
CORPORATION
(Exact
name of registrant as specified in its charter)
|
Delaware |
000-20852 |
16-1387013 |
|
(State of incorporation) |
(Commission File Number)
|
(IRS Employer Identification No.)
|
|
2000 Technology Parkway, Newark, New York |
14513 |
|
(Address of principal executive offices) |
(Zip Code) |
(315)
332-7100
(Registrant’s telephone number, including area
code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
⃞ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
⃞ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
⃞ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
⃞ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 8.01 Other Events.
Ultralife has received an order valued at $1.3 million from the Defense Logistics Agency (DLA) for its BA-5390 battery.
The information set forth in this Form 8-K and the attached exhibit is being furnished to and not filed with the Securities and Exchange Commission and shall not be deemed to be incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except to the extent specifically provided in any such filing.
Item 9.01. Financial Statements, and Exhibits
(d) Exhibits.
| Exhibit No. | Description | |
| 99.1 | Press Release, dated September 28, 2010. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: September 28, 2010 | ULTRALIFE CORPORATION | |
| /s/ Peter F. Comerford | ||
| Peter F. Comerford | ||
|
Vice President Administration & General Counsel |
Exhibit 99.1
Ultralife
Corporation Receives $1.3 Million Order for its BA 5390
Military
Batteries from Defense Logistics Agency
NEWARK, N.Y.--(BUSINESS WIRE)--September 28, 2010--Ultralife Corporation (NASDAQ: ULBI) has received an order valued at $1.3 million from the Defense Logistics Agency (DLA) for its BA-5390 battery. This order represents the first release under the 5-year Indefinite Quantity Contract that commenced on September 14, 2010. DLA has estimated the demand value for the base year at $5.3 million and has estimated the total award not to exceed $42.1 million. Deliveries under this order are anticipated to occur in the first half of 2011.
About Ultralife Corporation
Ultralife Corporation, which began as a battery company, serves its markets with products and services ranging from portable and standby power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe.
Headquartered in Newark, New York, the company's business segments include: Battery & Energy Products, Communications Systems and Energy Services. Ultralife has operations in North America, Europe and Asia. For more information, visit http://www.ultralifecorp.com.
CONTACT:
Company:
Ultralife Corporation
Philip
Fain, 315-332-7100
pfain@ulbi.com
or
Investor
Relations:
Lippert/Heilshorn & Associates, Inc.
Jody
Burfening, 212-838-3777
jburfening@lhai.com